Organ-on-Chip Market Growth Fueled by Tech Advancements, Projected to Surpass USD 1.15 Billion by 2029

Mordor Intelligence has published a new report on the Organs on Chips Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The Organ-on-Chip Market is projected to be valued at USD 0.3 billion in 2024 and is anticipated to grow to USD 1.1 billion by 2029, with a compound annual growth rate (CAGR) of 30.94% during the forecast period (2024-2029) and fueled by the demand for alternatives to animal testing, the necessity for early detection of drug toxicity, and advancements in technology coupled with new product launches.

Report Overview - https://www.mordorintelligence.com/industry-reports/organs-on-chips-market

Key Trends Driving the Organ-on-Chip Market

1. Technological Advancements and New Product Launches

Continuous innovation in organ-on-chip technology has led to the development of sophisticated models that closely mimic human organ functions. For instance, in December 2021, Emulate, Inc. announced that its Brain Chip was sent to the International Space Station (ISS) National Lab to study the effects of microgravity on human brain physiology. This initiative was part of the Tissue Chips in Space program, sponsored by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the ISS National Lab.

2. Demand for Alternatives to Animal Testing

The ethical concerns and limitations associated with animal testing have propelled the adoption of organ-on-chip technologies. These microfluidic devices offer a more accurate representation of human physiology, enabling better prediction of human responses to drugs and reducing the reliance on animal models. This shift is further supported by regulatory agencies advocating for alternative testing methods.

3. Early Detection of Drug Toxicity

Pharmaceutical companies are increasingly utilizing organ-on-chip systems for early-stage drug toxicity screening. These devices replicate human organ functions, allowing for the assessment of a drug's safety profile before clinical trials. This approach not only enhances patient safety but also reduces the time and cost associated with drug development.

4. Applications Beyond the Pharmaceutical Industry

The versatility of organ-on-chip technology extends its applications beyond pharmaceuticals into areas such as disease modeling, personalized medicine, and environmental toxin assessment. For example, in September 2021, Fidia Farmaceutici S.p.A. and BiomimX Srl entered into a research collaboration to introduce organ-on-chip-based technological solutions into the intra-articular medical device discovery process.

Market Segmentation

1. Organ Type

Lung-on-Chip: These devices simulate the human lung environment, facilitating studies on respiratory diseases and drug delivery mechanisms.

Liver-on-Chip: Replicates liver functions to assess drug metabolism and hepatotoxicity.

Heart-on-Chip: Models cardiac tissue behavior, aiding in cardiovascular research and drug testing.

Brain-on-Chip: Emulates the blood-brain barrier and neural activities, supporting neurological studies.

Other Organs: Includes kidney, gut, and skin-on-chip models, each serving specific research purposes.

2. Application

Drug Discovery and Development: Utilized for screening drug candidates and understanding their effects on human tissues.

Disease Modeling: Helps in studying disease progression and potential therapeutic interventions.

Toxicology Research: Assesses the safety and toxicity of chemicals and pharmaceuticals.

Personalized Medicine: Facilitates the development of tailored treatments based on individual patient responses.

3. End-User

Pharmaceutical and Biotechnology Companies: Employ organ-on-chip systems in R&D and drug testing processes.

Academic and Research Institutes: Use these devices for fundamental research and educational purposes.

Healthcare Providers: Incorporate organ-on-chip technology for diagnostic and therapeutic applications.

Get a Customized Report Tailored to Your Requirements:- https://www.mordorintelligence.com/market-analysis/healthcare-provider-it

Key Players

The organ-on-chip market is moderately consolidated, with several key players driving innovation and market growth. Major companies operating in this sector include:

Emulate, Inc.

MIMETAS BV

TissUse GmbH

AxoSim

BiomimX Srl

These companies are actively engaged in product development, strategic collaborations, and expanding their technological capabilities to strengthen their market positions.

Conclusion

The organ-on-chip market is on a robust growth trajectory, driven by technological advancements, ethical considerations, and the need for more accurate human models in research and development. The projected growth to USD 1.15 billion by 2029 underscores the increasing adoption of this technology across various sectors. As key players continue to innovate and expand their offerings, organ-on-chip systems are poised to play a pivotal role in transforming drug discovery, disease modeling, and personalized medicine, ultimately contributing to more effective and safer therapeutic solutions.

Industry Related Reports

Human Liver Models Market: The Human Liver Models Market is categorized by product type (2D Models, 3D Models, Liver-On-A-Chip, and Others), application (Education, Drug Discovery, and Others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/human-liver-models-market

Artificial Organs Market: The report emphasizes the growth of the Global Artificial Organ Market and the participating companies. It is categorized by organ type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, and Other Organ Types) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/global-artificial-organs-market-industry

France Artificial Organs Bionic Implants Market: The French Artificial Organs and Bionics Market is divided by type into Artificial Organs (Artificial Heart, Artificial Kidney, Cochlear Implants, and Other Organ Types) and Bionics (Vision Bionics, Ear Bionics, Orthopedic Bionics, and Cardiac Bionics).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/france-artificial-organs-bionic-implants-market

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.